XML 97 R78.htm IDEA: XBRL DOCUMENT v3.23.1
Discontinued operations (Details 2) - BRL (R$)
R$ in Thousands
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Discontinued operations      
Net revenue from sales and services R$ 143,634,708 R$ 109,732,842 R$ 74,058,056
Cost of products and services sold (136,276,257) (104,827,966) (70,056,447)
Gross profit 7,358,451 4,904,876 4,001,609
Operating income (expenses)      
Selling marketing and administrative (2,141,985) (1,931,666) (1,611,152)
Other operating income (expenses), net (514,522) 96,166 64,034
Operating income (loss) 3,336,752 1,787,014 1,545,960
Income (loss) before finance result and income and social contribution taxes 3,348,933 1,769,380 1,501,929
Financial result, net (1,469,208) (762,732) (550,348)
Income (loss) before income and social contribution taxes 1,879,725 1,006,648 951,581
Net income (loss) for the year 301,858 65,264 280,633
Depreciation and amortization for the year 1,525,567 1,196,355 1,127,637
Net cash provided by (used in) operating activities 30,550 982,519 874,106
Net cash (used in) provided by investing activities (220,190) (158,733) (487,390)
Net cash provided by (used in) financing activities (179,025) (552,967) (919,684)
Effect of exchange rate changes on cash and cash equivalents in foreign currency (19,316) 56,553 114,822
Extrafarma [member]      
Operating income (expenses)      
Impairment (427,529)    
Eliminations      
Discontinued operations      
Net revenue from sales and services (272,574) (214,715) (193,046)
Cost of products and services sold 266,122 194,118 133,384
Gross profit (6,452) (20,597) (59,662)
Operating income (expenses)      
Other operating income (expenses), net 0 0 0
Operating income (loss) 0 0 0
Income (loss) before finance result and income and social contribution taxes 0 0 0
Depreciation and amortization for the year (346) 0 0
Total Discontinued operations      
Discontinued operations      
Net revenue from sales and services 3,267,533 9,065,795 7,183,046
Cost of products and services sold (2,485,069) (6,901,181) (5,571,767)
Gross profit 782,464 2,164,614 1,611,279
Operating income (expenses)      
Selling marketing and administrative (639,966) (1,664,015)  
Impairment   (427,529)  
Other operating income (expenses), net 246,110 25,815  
Operating income (loss) 388,608 98,885 266,095
Share of profit (loss) of subsidiaries, joint ventures and associates (231) 48  
Income (loss) before finance result and income and social contribution taxes 388,377 98,933 266,509
Financial result, net 52,525 (146,970) 280,974
Income (loss) before income and social contribution taxes 440,902 (48,037) 547,483
Income and social contribution taxes (217,500) 113,301  
Net effect of cessation of depreciation [1] 78,456    
Net income (loss) for the year 301,858 65,264 280,633
Depreciation and amortization for the year   463,414 [2] 428,962 [3]
Net cash provided by (used in) operating activities 30,550 982,519  
Net cash (used in) provided by investing activities (220,190) (158,733)  
Net cash provided by (used in) financing activities (179,025) (552,967)  
Effect of exchange rate changes on cash and cash equivalents in foreign currency (19,316) 56,553  
Increase (decrease) in cash and cash equivalents (387,981) 327,372 (418,146)
Total Discontinued operations | Oxiteno S. A. Industria e Comercio [member]      
Discontinued operations      
Net revenue from sales and services 2,039,287 7,102,771 5,210,704
Cost of products and services sold (1,580,000) (5,540,773) (4,188,711)
Gross profit 459,287 1,561,998 1,021,993
Operating income (expenses)      
Selling marketing and administrative (201,365) (978,221)  
Impairment   0  
Other operating income (expenses), net 10,736 26,924  
Operating income (loss) 268,658 610,701 344,394
Share of profit (loss) of subsidiaries, joint ventures and associates (231) 48  
Income (loss) before finance result and income and social contribution taxes 268,427 610,749 344,808
Financial result, net 23,153 (431,441) 1,482
Income (loss) before income and social contribution taxes 291,580 179,308 346,290
Income and social contribution taxes (16,924) 69,995  
Net effect of cessation of depreciation [1] 51,372    
Net income (loss) for the year 326,028 249,303 0
Depreciation and amortization for the year   308,564 [2] 275,063 [3]
Net cash provided by (used in) operating activities (81,558) 1,016,580  
Net cash (used in) provided by investing activities 1,011,736 (122,363)  
Net cash provided by (used in) financing activities (1,245,754) (1,054,930)  
Effect of exchange rate changes on cash and cash equivalents in foreign currency (19,316) 56,553  
Increase (decrease) in cash and cash equivalents (334,892) (104,160) (515,927)
Total Discontinued operations | Extrafarma [member]      
Discontinued operations      
Net revenue from sales and services 1,235,487 1,986,932 1,988,411
Cost of products and services sold (912,310) (1,384,316) (1,399,125)
Gross profit 323,177 602,616 589,286
Operating income (expenses)      
Selling marketing and administrative (438,601) (685,794)  
Impairment   (427,529)  
Other operating income (expenses), net (5,951) (1,109)  
Operating income (loss) (121,375) (511,816) (78,299)
Share of profit (loss) of subsidiaries, joint ventures and associates 0 0  
Income (loss) before finance result and income and social contribution taxes (121,375) (511,816) (78,299)
Financial result, net (25,059) (45,265) (38,938)
Income (loss) before income and social contribution taxes (146,434) (557,081) (117,237)
Income and social contribution taxes 20,826 155,416  
Net effect of cessation of depreciation [1] 27,084    
Net income (loss) for the year (98,524) (401,665) 0
Depreciation and amortization for the year   154,850 [2] 153,899 [3]
Net cash provided by (used in) operating activities (68,370) (33,273)  
Net cash (used in) provided by investing activities (25,323) (35,072)  
Net cash provided by (used in) financing activities 40,585 35,286  
Effect of exchange rate changes on cash and cash equivalents in foreign currency 0 0  
Increase (decrease) in cash and cash equivalents (53,108) (33,059) 116,184
Total Discontinued operations | Ultrapar [Member]      
Discontinued operations      
Net revenue from sales and services 0    
Cost of products and services sold 0    
Gross profit 0    
Operating income (expenses)      
Selling marketing and administrative 0    
Other operating income (expenses), net 241,325    
Operating income (loss) 241,325    
Share of profit (loss) of subsidiaries, joint ventures and associates 0    
Income (loss) before finance result and income and social contribution taxes 241,325    
Financial result, net 0    
Income (loss) before income and social contribution taxes 241,325    
Income and social contribution taxes (202,895)    
Net effect of cessation of depreciation [1] 0    
Net income (loss) for the year 38,430    
Total Discontinued operations | Eliminations      
Discontinued operations      
Net revenue from sales and services (7,241) [4] (23,908) [5] (16,069)
Cost of products and services sold 7,241 [4] 23,908 [5] 16,069
Gross profit 0 [4] 0 [5] 0
Operating income (expenses)      
Selling marketing and administrative 0 [4] 0 [5]  
Impairment [5]   0  
Other operating income (expenses), net 0 [4] 0 [5]  
Operating income (loss) 0 [4] 0 [5] 0
Share of profit (loss) of subsidiaries, joint ventures and associates 0 [4] 0 [5]  
Income (loss) before finance result and income and social contribution taxes 0 [4] 0 [5] 0
Financial result, net 54,431 [4] 329,736 [5] 318,430
Income (loss) before income and social contribution taxes 54,431 [4] 329,736 [5] 318,430
Income and social contribution taxes (18,507) [4] (112,110) [5]  
Net effect of cessation of depreciation [1],[4] 0    
Net income (loss) for the year 35,924 [4] 217,626 [5] 0
Depreciation and amortization for the year   0 [2],[5] 0 [3]
Net cash provided by (used in) operating activities 180,478 (788)  
Net cash (used in) provided by investing activities (1,206,603) (1,298)  
Net cash provided by (used in) financing activities 1,026,144 466,677  
Effect of exchange rate changes on cash and cash equivalents in foreign currency 0 0  
Increase (decrease) in cash and cash equivalents R$ 19 R$ 464,591 R$ (18,403)
[1] As of January 1, 2022, the depreciation and amortization of assets classified as held for sale ceased, in compliance with item 25 of IFRS 5.
[2] Balances included for a complete breakdown of segment information.
[3] Balances included for complete breakdown of segment information.
[4] Elimination between continuing and discontinued operations related to the interest on the intercompany loan between Ultrapar International and Oxiteno.
[5] Elimination between the continued operations and discontinued operations related to loan between Ultrapar International and Oxiteno.